Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi - FierceBiotech
- Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi FierceBiotech
- Pfizer RSV vaccine that protects infants could receive FDA approval this summer CNBC
- 1st RSV vaccine could be approved by August, pending FDA review KABC-TV
- First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks Review Forbes
- U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review Yahoo Finance
- View Full Coverage on Google News